Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Intralesional Injection of Polidocanol 1% in Treatment of Keloids and Hypertrophic Scars

NCT07606391 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT07606391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07606391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Intralesional Injection of Polidocanol 1% in Treatment of Keloids and Hypertrophic Scars
Lead sponsor
Sohag University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
August 1, 2027
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

keloid and hypertrophic scars